NEO:CYBN
NEO:CYBN

Executive Medical &
Clinical Advisory Team

CHRIS SANKEY, M.D.

CLINIC ADVISOR
  • 20 years experience in the field of mental health and addiction and is currently the medical director of First Step Addiction Clinics,  Sunrise Clinics and the staff physician at the Satellite Comprehensive Opioid Addiction Treatment Centre in Toronto.

  • Held positions at the University of Toronto and CAMH. For the last decade he has been the Vice Chair of Addiction Medicine for the Ontario Medical Association and has worked as a supervisor for the College of Physicians and Surgeons of Ontario.

  • Previously appointed to a Minister of Health’s Task Force.

  • Contributed to scientific studies in mental health and was lead author for a recently published paper on patterns of opioid abuse in Ontario.

DOUG SOMMERVILLE

CHIEF PHARMACEUTICAL STRATEGIST
  • Former Country Head and Global SVP at Teva Canada, with record revenue exceeding $1.4B – more than 5 billion doses GMP production.

  • 25 years experience in pharma business development, R&D, M&A in domestic and international medical markets.

  • Past Chair of the Canadian Generic Pharmaceutical Association — $6B industry sales.

  • Former Global Vice President at Baxter Healthcare Corporation.

THOMAS ANDERSON

CLINICAL RESEARCH ADVISOR
  • Research Director and co-founder of the Psychedelic Studies Research Program (PSRP) at the University of Toronto.

  • Co-Founder of the Canadian Centre for Psychedelic Science which has published some of the first academic research on microdosing.

  • PhD candidate and cognitive neuroscientist with the Regulatory and Affective Dynamics (RAD) Lab of Norman Farb, an associate professor of psychology at U of T Mississauga.

  • Thomas’ research is some of the first on psychedelic microdosing.

  • Supported by the Natural Sciences and Engineering Council of Canada (NSERC) and the Stratas Foundation which recently awarded Thomas with an innovation award.

ROTEM PETRANKER

CLINICAL RESEARCH ADVISOR
  • Associate Director and co-founder of the Psychedelic Studies Research Program (PSRP) at the University of Toronto.

  • Co-Founder of the Canadian Centre for Psychedelic Science which has published some of the first academic research on microdosing.

  • BSc in psychology from the University of Toronto and an MA in social psychology from York University while currently undergoing his PhD candidacy at York University.

  • Main research interests include sustained attention, emotion regulation and creativity which are ostensibly affected by psychedelics.  Clinical interests include disorders amenable to psychedelic psychotherapy, including mood disorders and obsessive compulsive disorder.

LORENZO GORDON, M.D.

RESEARCH OPERATIONS ADVISOR
  • Current Vice Dean and Medical Director of the Caribbean School of Medical Sciences, Jamaica (CSMSJ) and is a graduate of the University of the West Indies, Mona.

  • Holds a Doctor of Philosophy in Biochemistry as well as a medical degree from the Higher Institute of Medical Sciences of Havana, Cuba.

  • Over 50 peer-reviewed publications.

  • Currently serves as a member of the Medicinal Cannabis Unit (MCU) Advisory Board Committee, Ministry of Health; and as a consultant to the Economic Growth Council on Cannabis-related matters; the Cannabis Licensing Authority (CLA), The Bureau of Standards; for Protocol Development and Research for cannabis.

ALAN RIDGEWAY PH.D.

HEALTHCARE RESEARCH ADVISOR
  • Worked as a publishing research analyst for more than 10 years, most recently at Sprott Capital Partners.

  • Prior to joining Sprott Capital Partners, he was a top ranked analyst at Scotiabank covering the healthcare sector.

  • Before working in the capital markets, Mr. Ridgeway held a postdoctoral fellowship at Harvard Medical School where he performed cancer research.

  • Mr. Ridgeway holds a Ph.D. in Biochemistry from Western University, an MBA from Queen’s University and is a CFA® Charterholder.

Goverment Relations
Advisory Team

ERIC HOSKINS, M.D., PH.D.

GOVERNMENT RELATIONS ADVISOR
  • Former Ontario health minister responsible for one of the largest health care systems in North America (2014 – 2018).

  • Former elected Member of Ontario Provincial Parliament with Cabinet positions in Health, Economic Development and Trade, Children and Youth Services, and Immigration.

  • Government of Canada Chair, Advisory Council on the Implementation of National Pharmacare.

  • Physician and public health specialist with more than thirty years’ experience in public policy, complex diplomacy, international affairs, health care, media and economic development at the intersection of business, politics and complex social and political circumstances.

  • Proven negotiator and navigator at the highest levels of government and bureaucracy.

ALEKSANDAR STOSIC

GOVERNMENT RELATIONS ADVISOR
  • Founding Partner and CEO at Stosic & Associates, a Canadian boutique government relations firm.

  • Executive Director to two senior Ontario Cabinet Ministers, including the Minister of Economic Development, Infrastructure, and Trade.

  • Has held senior roles at the Privy Council Office in Ottawa, the Toronto Region Board of Trade, and internationally in the natural resources sector.

  • Currently completing his PhD in Political Science.

DERRICK ARANEDA

GOVERNMENT RELATIONS ADVISOR
  • Partner at Stosic & Associates, a Canadian boutique government relations firm.

  • Chief of Staff to Ontario Minister of Health & Long-Term Care from 2016 – 2018.

  • Director roles from 2014-2016 with Ontario Government.

  • MBA, IE Business School, Madrid, Spain.

  • Previous work experience in Japan & Spain with high-growth education & technology start-ups.

Advisory Team

DENNIS MCKENNA

ADVISOR
  • Professional and personal interests are focused on the interdisciplinary study of ethnopharmacology and natural psychedelics.

  • 1979- 84 – Ph.D., Botanical Sciences, University of British Columbia.

  • 1990-93– Director of Ethnopharmacology, Shaman Pharmaceuticals, San Carlos California.

  • 2001-2017 – Adjunct Assistant Professor, Center for Spirituality and Healing, Academic Health Center, University of Minnesota.

  • 1993 – Present — Founding Board member, Heffter Research Institute.

  • 1993 – Organizer and key investigator, Hoasca Project, an international biomedical study of ayahuasca use by the UDV, a Brazilian religion.

  • 2017 – Organized 50th Anniversary Symposium, Ethnopharmacologic Search for Psychoactive Drugs (ESPD50), Buckinghamshire, UK.

  • Spring 2019 – Founded the McKenna Academy of Natural Philosophy as a provincial non-profit in British Columbia.

MICHAEL AUERBACH

ADVISOR
  • Entrepreneur, investor, business consultant, media producer, and private diplomat. 

  • Founder of Subversive Capital, which is dedicated to investing in radical companies whose core missions subvert the status quo and require sophisticated government and regulatory strategies for success.

  • General Partner of Subversive’s venture platform and Opportunity Fund, and Chairman of Subversive REIT LP and Subversive Capital Acquisition Corp.

  • Board member of Tilray, Inc. – the first Nasdaq-listed global cannabis company.

  • In his capacity as a private diplomat, Mr. Auerbach serves as a Senior Vice President at Albright Stonebridge Group, the global consulting firm chaired by former Secretary of State Madeleine Albright.

  • Prior to joining ASG, Michael founded and then sold a risk consulting firm to Control Risks – a leading global risk consulting firm. 

  • Michael started his career during the dot-com boom of the late 1990s running Panopticon Inc., a VC incubator concentrating on internet and mobile technology.

  • Held senior positions at the Center for American Progress and The Century Foundation, where he concentrated on issues related to U.S. Foreign Policy, National Security, and Conflict Resolution.

  • Served as a Visiting Professor at the New School for Social Research and also taught at the University of Cape Town and Cyprus College. 

  • Presently sits on the boards of the Theodore C. Sorensen Center for International Peace and Justice, The KiDS Board of NYU’s Hassenfeld Children’s Hospital, Next for Autism, which produces Night of Too Many Stars, and Sophie Gerson Healthy Youth Foundation. 

  • Mr. Auerbach received a M.A. in International Relations from Columbia University and a B.A. in Critical Theory from the New School for Social Research.